Do analysts recommend RDGT or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, RDGT or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.02 -$1.25M N/A N/A Hong Kong Pharma Digital Technology $13.43M 0.09 -$1.14M N/A N/A

Is RDGT or HKPD more profitable?

Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Hong Kong Pharma Digital Technology N/A N/A N/A

Do analysts recommend MCK or RDGT?

McKesson presently has a consensus target price of $973.44, indicating a potential upside of 11.37%. Given McKesson's stronger consensus rating and higher possible upside, analysts plainly believe McKesson is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score McKesson 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.78 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, MCK or RDGT?

McKesson has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.25 $4.76B $37.37 23.39 Ridgetech $132.16M 0.02 -$1.25M N/A N/A

Is MCK or RDGT more profitable?

McKesson has a net margin of 1.12% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Ridgetech N/A N/A N/A

Do analysts rate RDGT or COR?

Cencora has a consensus price target of $370.85, suggesting a potential upside of 20.16%. Given Cencora's stronger consensus rating and higher possible upside, analysts clearly believe Cencora is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cencora 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.81

Which has higher earnings & valuation, RDGT or COR?

Cencora has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.02 -$1.25M N/A N/A Cencora $321.33B 0.18 $1.55B $13.46 22.93

Is RDGT or COR more profitable?

Cencora has a net margin of 0.79% compared to Ridgetech's net margin of 0.00%. Cencora's return on equity of 125.45% beat Ridgetech's return on equity. Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Cencora 0.79% 125.45% 4.18%

Do analysts rate CAH or RDGT?

Cardinal Health currently has a consensus price target of $266.56, suggesting a potential upside of 18.50%. Given Cardinal Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Cardinal Health is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardinal Health 0 Sell rating(s) 3 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.84 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, CAH or RDGT?

Cardinal Health has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardinal Health $254.25B 0.21 $1.71B $7.23 31.11 Ridgetech $132.16M 0.02 -$1.25M N/A N/A

Do analysts recommend HSIC or RDGT?

Henry Schein presently has a consensus target price of $92.93, suggesting a potential upside of 9.54%. Given Henry Schein's stronger consensus rating and higher probable upside, equities research analysts clearly believe Henry Schein is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Henry Schein 1 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.53 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, HSIC or RDGT?

Henry Schein has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Henry Schein $13.18B 0.72 $398M $3.43 24.73 Ridgetech $132.16M 0.02 -$1.25M N/A N/A

Ridgetech (RDGT) Competitors

$0.91 -0.01 (-1.10%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.94 +0.03 (+2.86%)

As of 09/18/2026 07:50 PM Eastern

Compare

RDGT vs. HKPD, MCK, COR, CAH, and HSIC

Should you buy Ridgetech stock or one of its competitors? Ridgetech's main competitors and comparable companies include Hong Kong Pharma Digital Technology (HKPD), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), and Henry Schein (HSIC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Ridgetech compare to Hong Kong Pharma Digital Technology?

Ridgetech (NASDAQ:RDGT) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ridgetech has a beta of -0.08, meaning that its share price is 108% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.23, meaning that its share price is 123% more volatile than the broader market.

In the previous week, Ridgetech's average media sentiment score of 0.00 equaled Hong Kong Pharma Digital Technology'saverage media sentiment score.

Company	Overall Sentiment
Ridgetech	Neutral
Hong Kong Pharma Digital Technology	Neutral

45.3% of Ridgetech shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.09	-$1.14M	N/A	N/A

Summary

Ridgetech and Hong Kong Pharma Digital Technology tied by winning 3 of the 6 factors compared between the two stocks.

How does Ridgetech compare to McKesson?

McKesson (NYSE:MCK) and Ridgetech (NASDAQ:RDGT) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

McKesson presently has a consensus target price of $973.44, indicating a potential upside of 11.37%. Given McKesson's stronger consensus rating and higher possible upside, analysts plainly believe McKesson is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

McKesson has a net margin of 1.12% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Ridgetech	N/A	N/A	N/A

85.1% of McKesson shares are held by institutional investors. Comparatively, 45.3% of Ridgetech shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 22.6% of Ridgetech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

McKesson has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$37.37	23.39
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A

In the previous week, McKesson had 14 more articles in the media than Ridgetech. MarketBeat recorded 14 mentions for McKesson and 0 mentions for Ridgetech. McKesson's average media sentiment score of 0.62 beat Ridgetech's score of 0.00 indicating that McKesson is being referred to more favorably in the media.

Company	Overall Sentiment
McKesson	Positive
Ridgetech	Neutral

McKesson has a beta of 0.3, meaning that its stock price is 70% less volatile than the broader market. Comparatively, Ridgetech has a beta of -0.08, meaning that its stock price is 108% less volatile than the broader market.

Summary

McKesson beats Ridgetech on 12 of the 14 factors compared between the two stocks.

How does Ridgetech compare to Cencora?

Ridgetech (NASDAQ:RDGT) and Cencora (NYSE:COR) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

Cencora has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A
Cencora	$321.33B	0.18	$1.55B	$13.46	22.93

In the previous week, Cencora had 13 more articles in the media than Ridgetech. MarketBeat recorded 13 mentions for Cencora and 0 mentions for Ridgetech. Cencora's average media sentiment score of 0.82 beat Ridgetech's score of 0.00 indicating that Cencora is being referred to more favorably in the news media.

Company	Overall Sentiment
Ridgetech	Neutral
Cencora	Positive

45.3% of Ridgetech shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 22.6% of Ridgetech shares are held by insiders. Comparatively, 0.4% of Cencora shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Ridgetech has a beta of -0.08, meaning that its share price is 108% less volatile than the broader market. Comparatively, Cencora has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market.

Cencora has a consensus price target of $370.85, suggesting a potential upside of 20.16%. Given Cencora's stronger consensus rating and higher possible upside, analysts clearly believe Cencora is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81

Cencora has a net margin of 0.79% compared to Ridgetech's net margin of 0.00%. Cencora's return on equity of 125.45% beat Ridgetech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Cencora	0.79%	125.45%	4.18%

Summary

Cencora beats Ridgetech on 13 of the 14 factors compared between the two stocks.

How does Ridgetech compare to Cardinal Health?

Cardinal Health (NYSE:CAH) and Ridgetech (NASDAQ:RDGT) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk and analyst recommendations.

87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 45.3% of Ridgetech shares are held by institutional investors. 0.1% of Cardinal Health shares are held by insiders. Comparatively, 22.6% of Ridgetech shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cardinal Health has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market. Comparatively, Ridgetech has a beta of -0.08, indicating that its stock price is 108% less volatile than the broader market.

Cardinal Health has a net margin of 0.67% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.67%	-98.53%	4.69%
Ridgetech	N/A	N/A	N/A

Cardinal Health has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$254.25B	0.21	$1.71B	$7.23	31.11
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A

Cardinal Health currently has a consensus price target of $266.56, suggesting a potential upside of 18.50%. Given Cardinal Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Cardinal Health is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.84
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Cardinal Health had 13 more articles in the media than Ridgetech. MarketBeat recorded 13 mentions for Cardinal Health and 0 mentions for Ridgetech. Cardinal Health's average media sentiment score of 0.83 beat Ridgetech's score of 0.00 indicating that Cardinal Health is being referred to more favorably in the media.

Company	Overall Sentiment
Cardinal Health	Positive
Ridgetech	Neutral

Summary

Cardinal Health beats Ridgetech on 12 of the 14 factors compared between the two stocks.

How does Ridgetech compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Ridgetech (NASDAQ:RDGT) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Henry Schein has a net margin of 2.96% compared to Ridgetech's net margin of 0.00%. Henry Schein's return on equity of 15.97% beat Ridgetech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Ridgetech	N/A	N/A	N/A

Henry Schein presently has a consensus target price of $92.93, suggesting a potential upside of 9.54%. Given Henry Schein's stronger consensus rating and higher probable upside, equities research analysts clearly believe Henry Schein is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 45.3% of Ridgetech shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 22.6% of Ridgetech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Henry Schein has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market. Comparatively, Ridgetech has a beta of -0.08, suggesting that its share price is 108% less volatile than the broader market.

In the previous week, Henry Schein had 6 more articles in the media than Ridgetech. MarketBeat recorded 6 mentions for Henry Schein and 0 mentions for Ridgetech. Henry Schein's average media sentiment score of 0.75 beat Ridgetech's score of 0.00 indicating that Henry Schein is being referred to more favorably in the media.

Company	Overall Sentiment
Henry Schein	Positive
Ridgetech	Neutral

Henry Schein has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.72	$398M	$3.43	24.73
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A

Summary

Henry Schein beats Ridgetech on 13 of the 14 factors compared between the two stocks.

Get Ridgetech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RDGT vs. The Competition

Export

Metric	Ridgetech	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.30M	$9.75B	$7.24B	$13.21B
Dividend Yield	N/A	2.62%	2.57%	12.80%
P/E Ratio	N/A	34.09	275.49	25.40
Price / Sales	0.02	4.98	639.63	86.88
Price / Cash	N/A	121.76	76.25	51.42
Price / Book	0.02	5.30	10.46	6.33
Net Income	-$1.25M	$313.45M	$3.49B	$358.33M
7 Day Performance	9.78%	1.65%	0.59%	1.12%
1 Month Performance	12.95%	-0.85%	-1.74%	-2.39%
1 Year Performance	-99.55%	16.30%	18.13%	5.35%

Ridgetech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RDGT Ridgetech	0.8129 of 5 stars	$0.91 -1.1%	N/A	-99.6%	$3.30M	$132.16M	N/A	980	Gap Up
HKPD Hong Kong Pharma Digital Technology	0.7907 of 5 stars	$0.12 +4.9%	N/A	-91.5%	$1.31M	$13.43M	N/A	19	Short Interest Decrease High Trading Volume
MCK McKesson	4.3966 of 5 stars	$888.29 -1.3%	$973.44 +9.6%	+25.2%	$103.57B	$403.43B	23.77	43,000
COR Cencora	4.9071 of 5 stars	$318.54 -1.5%	$370.85 +16.4%	+6.3%	$60.79B	$321.33B	23.67	51,000
CAH Cardinal Health	4.729 of 5 stars	$232.56 0.0%	$266.56 +14.6%	+50.4%	$54.09B	$254.25B	32.17	63,900	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RDGT) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ridgetech (RDGT) Competitors

RDGT vs. HKPD, MCK, COR, CAH, and HSIC

How does Ridgetech compare to Hong Kong Pharma Digital Technology?

Summary

How does Ridgetech compare to McKesson?

Summary

How does Ridgetech compare to Cencora?

Summary

How does Ridgetech compare to Cardinal Health?

Summary

How does Ridgetech compare to Henry Schein?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDGT vs. The Competition

Ridgetech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ridgetech (RDGT) Competitors

RDGT vs. HKPD, MCK, COR, CAH, and HSIC

How does Ridgetech compare to Hong Kong Pharma Digital Technology?

Is RDGT or HKPD more profitable?

Do analysts recommend RDGT or HKPD?

Which has more volatility and risk, RDGT or HKPD?

Does the media favor RDGT or HKPD?

Do insiders and institutionals hold more shares of RDGT or HKPD?

Which has better valuation & earnings, RDGT or HKPD?

Summary

How does Ridgetech compare to McKesson?

Do analysts recommend MCK or RDGT?

Is MCK or RDGT more profitable?

Do institutionals and insiders have more ownership in MCK or RDGT?

Which has stronger earnings and valuation, MCK or RDGT?

Does the media favor MCK or RDGT?

Which has more risk and volatility, MCK or RDGT?

Summary

How does Ridgetech compare to Cencora?

Which has higher earnings & valuation, RDGT or COR?

Does the media refer more to RDGT or COR?

Do insiders & institutionals believe in RDGT or COR?

Which has more risk and volatility, RDGT or COR?

Do analysts rate RDGT or COR?

Is RDGT or COR more profitable?

Summary

How does Ridgetech compare to Cardinal Health?

Do insiders and institutionals hold more shares of CAH or RDGT?

Which has more risk & volatility, CAH or RDGT?

Is CAH or RDGT more profitable?

Which has higher valuation & earnings, CAH or RDGT?

Do analysts rate CAH or RDGT?

Does the media favor CAH or RDGT?

Summary

How does Ridgetech compare to Henry Schein?

Is HSIC or RDGT more profitable?

Do analysts recommend HSIC or RDGT?

Do institutionals & insiders hold more shares of HSIC or RDGT?

Which has more volatility & risk, HSIC or RDGT?

Does the media favor HSIC or RDGT?

Which has preferable earnings and valuation, HSIC or RDGT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDGT vs. The Competition

Ridgetech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools